tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BMYBristol Myers Squibb

Health care · Pharmaceuticals · NYSE

Bristol-Myers Squibb Company ("we", the "Company", "Bristol Myers Squibb", or "BMS") was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. 10-K, Item 1

Employees
32,500
Headquarters
Princeton, NJ
CEO
Christopher S. Boerner
Next results
around Feb 4, 2027
Compare with peers → Embed

What BMY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans adopted or ended

InsiderWhatDateSharesRuns toReported in
David V. Elkins
Chief Financial Officer
Adopted 10b5-1 plan Jun 3, 2025 up to 86,000 May 1, 2026 10-Q Jul 31, 2025
The company's description
On June 3, 2025, David V. Elkins, Chief Financial Officer, adopted a "Rule 10b5-1 trading arrangement" that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for the sale of up to 86,000 shares of the Company's common stock, subject to certain conditions. The expiration date for the trading arrangement is May 1, 2026, or such earlier date upon which all transactions are completed. No other director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K during the period covered by this Quarterly Report on Form 10-Q.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 27, 2023.

Form 144 notices of planned sales

FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Nov 6, 2026 Julia A Haller Gottsch
Director
3,800 $250,000 stock bonus none given none found
Sep 9, 2026 Massacesi Cristian
Officer
6,249 $403,498 Restricted Stock Vesting none given 6,249 shares from Sep 9, 2026
Aug 25, 2026 Holzer Phil M
Officer
500 $33,750 Restricted Stock Vesting none given 500 shares from Aug 25, 2026
Apr 1, 2026 Elkins David V
Officer
30,000 $1,850,645 Restricted Stock Vesting adopted Jun 3, 2025 none found

From the Form 144 XML filed with the SEC, since Apr 1, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Work on BMY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/BMY/export.csv") into a cell.